Type: Breast cancer
This study will explore whether certain microRNAS could be targeted in combination with chemotherapy to kill breast cancer cells and improve patient outcomes.
Professor Bettina Meiser is leading a world-first study on the impacts of testing women for common, low-risk genetic variants that can lead to breast cancer.
Professor Christopher Ormandy is driving the next generation of revolutionary breast cancer treatments. His team has identified pathways that turn normal breast cells into cancer.
Chemotherapy is the most common treatment for triple negative breast cancer, but the disease often comes back. Prof Baxter’s team is studying possible new drug combinations.